Evaluation of Tiotropium 5 µg/Day Delivered Via the Respimat® Inhaler Over 48 Weeks in Patients With Severe Persistent Asthma on Top of Usual Care (Study II)

205.417.01061 Boehringer Ingelheim Investigational Site, Fountain Valley

205.417.01052 Boehringer Ingelheim Investigational Site, Fresno

205.417.01051 Boehringer Ingelheim Investigational Site, Stockton

205.417.01056 Boehringer Ingelheim Investigational Site, Waterbury

205.417.01065 Boehringer Ingelheim Investigational Site, Pensacola

205.417.01059 Boehringer Ingelheim Investigational Site, Chicago

205.417.01068 Boehringer Ingelheim Investigational Site, Normal

205.417.01063 Boehringer Ingelheim Investigational Site, Louisville

205.417.01064 Boehringer Ingelheim Investigational Site, New Orleans

205.417.01066 Boehringer Ingelheim Investigational Site, Omaha

205.417.01069 Boehringer Ingelheim Investigational Site, Ocean City

205.417.01062 Boehringer Ingelheim Investigational Site, Albany

205.417.01058 Boehringer Ingelheim Investigational Site, Great Neck

205.417.01055 Boehringer Ingelheim Investigational Site, Rockville Centre

205.417.01067 Boehringer Ingelheim Investigational Site, High Point

205.417.01070 Boehringer Ingelheim Investigational Site, Canton

205.417.01053 Boehringer Ingelheim Investigational Site, Upland

205.417.01054 Boehringer Ingelheim Investigational Site, Richmond

205.417.61051 Boehringer Ingelheim Investigational Site, Concord

205.417.02051 Boehringer Ingelheim Investigational Site, Mississauga

205.417.02053 Boehringer Ingelheim Investigational Site, Ottawa

205.417.02052 Boehringer Ingelheim Investigational Site, Montreal

205.417.45052 Boehringer Ingelheim Investigational Site, Aalborg

205.417.45051 Boehringer Ingelheim Investigational Site, Aarhus C

205.417.49052 Boehringer Ingelheim Investigational Site, Berlin

205.417.49054 Boehringer Ingelheim Investigational Site, Hamburg

205.417.49053 Boehringer Ingelheim Investigational Site, Lübeck

205.417.49051 Boehringer Ingelheim Investigational Site, Rüdersdorf

205.417.49055 Boehringer Ingelheim Investigational Site, Weinheim

205.417.39052 Boehringer Ingelheim Investigational Site, Bussolengo (vr)

205.417.39054 Boehringer Ingelheim Investigational Site, Milan

205.417.39051 Boehringer Ingelheim Investigational Site, Pavia

205.417.39053 Boehringer Ingelheim Investigational Site, Pietra Ligure (sv)

205.417.81063 Boehringer Ingelheim Investigational Site, Himeji, Hyogo

205.417.81056 Boehringer Ingelheim Investigational Site, Hiroshima, Hiroshima

205.417.81051 Boehringer Ingelheim Investigational Site, Itabashi-ku, Tokyo

205.417.81059 Boehringer Ingelheim Investigational Site, Kagoshima, Kagoshima

205.417.81053 Boehringer Ingelheim Investigational Site, Kishiwada, Osaka

205.417.81057 Boehringer Ingelheim Investigational Site, Kitakyusyu, Fukuoka

205.417.81058 Boehringer Ingelheim Investigational Site, Koga, Fukuoka

205.417.81055 Boehringer Ingelheim Investigational Site, Kurashiki, Okayama

205.417.81064 Boehringer Ingelheim Investigational Site, Kurume, Fukuoka

205.417.81062 Boehringer Ingelheim Investigational Site, Morioka, Iwate

205.417.81052 Boehringer Ingelheim Investigational Site, Osaka-sayama, Osaka

205.417.81066 Boehringer Ingelheim Investigational Site, Sendai, Miyagi

205.417.81065 Boehringer Ingelheim Investigational Site, Seto, Aichi

205.417.81060 Boehringer Ingelheim Investigational Site, Urasoe, Okinawa

205.417.81061 Boehringer Ingelheim Investigational Site, Urasoe, Okinawa

205.417.81054 Boehringer Ingelheim Investigational Site, Wakayama, Wakayama

205.417.31051 Boehringer Ingelheim Investigational Site, Groningen

205.417.31053 Boehringer Ingelheim Investigational Site, Leeuwarden

205.417.31052 Boehringer Ingelheim Investigational Site, Schiedam

205.417.64054 Boehringer Ingelheim Investigational Site, Auckland NZ

205.417.64053 Boehringer Ingelheim Investigational Site, Christchurch

205.417.64052 Boehringer Ingelheim Investigational Site, Newtown Wellington NZ

205.417.64051 Boehringer Ingelheim Investigational Site, Tauranga

205.417.07051 Boehringer Ingelheim Investigational Site, Saint Petersburg

205.417.07052 Boehringer Ingelheim Investigational Site, Saint Petersburg

205.417.07053 Boehringer Ingelheim Investigational Site, Saint Petersburg

205.417.38153 Boehringer Ingelheim Investigational Site, Belgrade

205.417.38152 Boehringer Ingelheim Investigational Site, Kamenitz

205.417.38151 Boehringer Ingelheim Investigational Site, Niš

205.417.27051 Boehringer Ingelheim Investigational Site, Bellville

205.417.27052 Boehringer Ingelheim Investigational Site, Cape Town

205.417.27053 Boehringer Ingelheim Investigational Site, Cape Town

205.417.27054 Boehringer Ingelheim Investigational Site, Cape Town

205.417.90052 Boehringer Ingelheim Investigational Site, Ankara

205.417.90053 Boehringer Ingelheim Investigational Site, Ankara

205.417.90051 Boehringer Ingelheim Investigational Site, İzmit

205.417.38053 Boehringer Ingelheim Investigational Site, Kharkiv

205.417.38051 Boehringer Ingelheim Investigational Site, Kiev

205.417.38052 Boehringer Ingelheim Investigational Site, Vinnytsia

205.417.44051 Boehringer Ingelheim Investigational Site, Chertsey

205.417.44053 Boehringer Ingelheim Investigational Site, Exeter

205.417.44052 Boehringer Ingelheim Investigational Site, Windsor